Town and Country Compounding Sermorelin Injection Recall: Microbial Contamination Risk
Town and Country Compounding recalls Sermorelin/GHRP-6 injections with Bacillus circulans contamination. This poses a non-sterility risk requiring immediate action.
Stop using this now
Non-Sterility; microbial contamination identified as Bacillus circulans
Contact the company
What happened, in plain English
Town and Country Compounding has recalled Sermorelin/GHRP-6 injections due to microbial contamination. Using these products could lead to infections from the identified bacteria. Read more at govinfonow.com/recall/42508-town-and-country-compounding-sermorelin-injection-recall-microbial-contamination-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/42508-town-and-country-compounding-sermorelin-injection-recall-microbial-contamination-risk · Updated October 9, 2026 · FDA enforcement record: FDA #D-0228-2017
Cite this page
“Town and Country Compounding Sermorelin Injection Recall: Microbial Contamination Risk.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42508-town-and-country-compounding-sermorelin-injection-recall-microbial-contamination-risk. Based on FDA recall #D-0228-2017 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0228-2017%22&limit=1).
Why it’s dangerous
The injections contain Bacillus circulans, a bacterium that can cause infections. Microbial contamination in injectable drugs poses serious health risks if the product is used.
Who’s affected
Patients prescribed Sermorelin/GHRP-6 injections by healthcare providers in the U.S. are affected. Those using the recalled lot numbers are at highest risk.
How to tell if you have this one
Check for the product name 'Sermorelin/GHRP-6 Injection 6 mg-3 mg Lyophylized I, 2 mL vial, Rx' from Town and Country Compounding. The specific lot number is 07172016@1 with an expiration date of January 13, 2017.
- Brand
Town and Country Compounding- Category
Drug
What to do — step by step
Stop Using Immediately
Discard the recalled vial as it contains harmful bacteria that could cause infection.
Where it went and when
Where it was distributed
Distributed in 4 states, and outside the U.S.
FDA distribution: “MA, NY, NJ & FL; Canada” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Florida, Massachusetts, New Jersey, New York.
Recall timeline
FDA terminated this recall 3.2 years after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0228-2017 (August 1, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0228-2017 to see it in context.
- Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.